Skip to main content
. 2021 May 3;12:631204. doi: 10.3389/fphar.2021.631204

FIGURE 8.

FIGURE 8

Comparison of treatment-related AEs in CGRP monoclonal antibody vs. placebo and botulinum toxin vs. placebo.